Literature DB >> 27552077

Vitamin D: a 'wanted' supernatural power or a power of wishful thinking.

Stanisław Wroński1.   

Abstract

Entities:  

Year:  2016        PMID: 27552077      PMCID: PMC4986310          DOI: 10.5173/ceju.2016.861

Source DB:  PubMed          Journal:  Cent European J Urol        ISSN: 2080-4806


× No keyword cloud information.
The current issue of CEJU brings a somewhat ambiguous paper entitled “Vitamin D and urological cancers” describing (possible) role of the vit. D in the etiology of urological cancers [1]. Indeed, last years brought numerous publications presenting that 1,25-dihydroxyvitamin D3 may alter human susceptibility to different diseases (even improve fitness) and its capability to cure or, at least, to soothe some human cancers [2, 3, 4]. Such contribution of the vit. D has been debated widely elsewhere, became trendy in contemporary medicine and engaged a great number of researches. Vit D and polymorphism of its targeted receptors have been harnessed to the etiology of: hypertension, bronchial asthma, type 2 diabetes mellitus, autoimmune disorders, cognitive decline and so forth [5]. Some studies suggest that vit. D receptor polymorphism may play a role in the prostate cancer, bladder cancer and other malicious tumours [6, 7]. Its role in the progress of the colon cancer has been scientifically proven [6]. The evidence for a protective effect of vitamin D on the risk of breast cancer has been published before. Thus, it looked that medicine found a gorgeous but simple and attainable remedy for almost everything. Paper under discussion keeps pace with that papers and I am convinced that is worthy of notice as a well-tailored analysis adding a new twist to that issue [1]. Although considerable progress has been made toward understanding tumours etiology and the role of vit. D in human pathology, its role in cancer is still unclear [8, 9], Some papers present conflicting data clearly demonstrated in the manuscript under debate. Authors performed a survey of eligible studies on above mentioned possible association [1]. Its real scientific merit consist in concentration of a large group of data – it is an undisputed value of that paper. Apparently, pinning high hopes on the vit D is a risky business. A consultative committee – US Preventive Services Task Force concluded that all these data are insufficient [10]. Probably other factors that contribute to overall good health status, like healthy lifestyle with befitting physical activity, keeping healthy and balanced diet may intermingle with vit D level. In the light of that it is possible that some trials confused causes and effects. Well, a distinction should be made between the primary and secondary outcome but we do not confidently know which came first: the chicken or the egg? Moreover, next trials questioned the validity of before published research. A large volume meta-analysis (290 prospective observational studies and 172 random trials) indeed confirmed inversely proportional interrelation of the level of vit. D and incidence of cardiovascular, metabolic, inflammatory, neurologic and psychiatric disorders (even Alzheimer disease) but could not indicate the primary cause and secondary effect. Also, another authors found that vit. D supplementation had at most insignificant therapeutic effect on the above conditions [11]. It is apparent that the existing evidence to guide us on the subject of the vit. D supplementation is vague and volatile and is based on conflicting data. Nevertheless, there is one certain axiom that have emerged from above citations: complying with balanced, sagacious and healthy life style undoubtedly helps to keep vit. D and the risk of numerous diseases on a safe level.
  10 in total

1.  Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation.

Authors:  F C Garland; C F Garland; E D Gorham; J F Young
Journal:  Prev Med       Date:  1990-11       Impact factor: 4.018

2.  Vitamin D research and clinical practice: at a crossroads.

Authors:  JoAnn E Manson; Shari S Bassuk
Journal:  JAMA       Date:  2015-04-07       Impact factor: 56.272

Review 3.  Calcium and vitamin D. Their potential roles in colon and breast cancer prevention.

Authors:  C F Garland; F C Garland; E D Gorham
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

4.  Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.

Authors:  Irene M Shui; Lorelei A Mucci; Peter Kraft; Rulla M Tamimi; Sara Lindstrom; Kathryn L Penney; Katharina Nimptsch; Bruce W Hollis; Natalie Dupre; Elizabeth A Platz; Meir J Stampfer; Edward Giovannucci
Journal:  J Natl Cancer Inst       Date:  2012-04-12       Impact factor: 13.506

5.  Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.

Authors:  Joan M Lappe; Dianne Travers-Gustafson; K Michael Davies; Robert R Recker; Robert P Heaney
Journal:  Am J Clin Nutr       Date:  2007-06       Impact factor: 7.045

Review 6.  Vitamin D status and ill health: a systematic review.

Authors:  Philippe Autier; Mathieu Boniol; Cécile Pizot; Patrick Mullie
Journal:  Lancet Diabetes Endocrinol       Date:  2013-12-06       Impact factor: 32.069

7.  Vitamin D and physical performance in elderly subjects: the Pro.V.A study.

Authors:  Elena D Toffanello; Egle Perissinotto; Giuseppe Sergi; Sabina Zambon; Estella Musacchio; Stefania Maggi; Alessandra Coin; Leonardo Sartori; Maria-Chiara Corti; Giovannella Baggio; Gaetano Crepaldi; Enzo Manzato
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

8.  Primary vitamin D target genes allow a categorization of possible benefits of vitamin D₃ supplementation.

Authors:  Carsten Carlberg; Sabine Seuter; Vanessa D F de Mello; Ursula Schwab; Sari Voutilainen; Kari Pulkki; Tarja Nurmi; Jyrki Virtanen; Tomi-Pekka Tuomainen; Matti Uusitupa
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

9.  Vitamin D metabolic pathway genes and pancreatic cancer risk.

Authors:  Hannah Arem; Kai Yu; Xiaoqin Xiong; Kristin Moy; Neal D Freedman; Susan T Mayne; Demetrius Albanes; Alan A Arslan; Melissa Austin; William R Bamlet; Laura Beane-Freeman; Paige Bracci; Federico Canzian; Michelle Cotterchio; Eric J Duell; Steve Gallinger; Graham G Giles; Michael Goggins; Phyllis J Goodman; Patricia Hartge; Manal Hassan; Kathy Helzlsouer; Brian Henderson; Elizabeth A Holly; Robert Hoover; Eric J Jacobs; Aruna Kamineni; Alison Klein; Eric Klein; Laurence N Kolonel; Donghui Li; Núria Malats; Satu Männistö; Marjorie L McCullough; Sara H Olson; Irene Orlow; Ulrike Peters; Gloria M Petersen; Miquel Porta; Gianluca Severi; Xiao-Ou Shu; Kala Visvanathan; Emily White; Herbert Yu; Anne Zeleniuch-Jacquotte; Wei Zheng; Geoffrey S Tobias; Dennis Maeder; Michelle Brotzman; Harvey Risch; Joshua N Sampson; Rachael Z Stolzenberg-Solomon
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

10.  Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.

Authors:  Sharon L McDonnell; Carole Baggerly; Christine B French; Leo L Baggerly; Cedric F Garland; Edward D Gorham; Joan M Lappe; Robert P Heaney
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.